Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 18, 2020
Patent Application Number
16109017
Date Filed
August 22, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides an antibody or an antigen-binding fragment thereof with binding specificity for human interleukin-1 receptor accessory protein (IL1RAP) wherein the antibody or antigen-binding fragment is capable of inhibiting to domain 3 of human IL1RAP. The invention further provides the use of such antibodies or an antigen-binding fragments in the treatment and/or diagnosis of cancers, such as leukemias and melanoma.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
